Company: EDSA
Filing Date: 2025-07-25
Form Type: S-3
Source: 0001171843-25-004721
Chunk: 36

Company: Edesa Biotech, Inc.
Filing Date: 2025-07-25
Form: S-3
Chunk 36
---
 reference into such documents). Requests for such copies should be directed to

<div align='center'>Edesa Biotech, Inc.
Attention: Investor Relations
100 Spy Court
Markham, Ontario L3R 5H6 Canada
Tel. (289) 800-9600</div>

| 27 |

<div align='center'>$150,000,000

Common Shares

Preferred Shares

Warrants

Debt Securities

Subscription Rights

Units

PROSPECTUS

, 2025

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 14. Other Expenses of Issuance and Distribution.

The following table sets forth the costs and expenses payable in connection with the sale and distribution of the securities being registered hereby.

| EXPENSE                      |     | AMOUNT |        |    |
|:-----------------------------|:----|:-------|-------:|---:|
| SEC Registration Fee         |     | $      | 905.88 | -1 |
| Legal Fees and Expenses      |     |        |      * |    |
| Accounting Fees and Expenses |     |        |      * |    |
| Trustee Fees                 |     |        |      * |    |
| Printing                     |     |        |      * |    |
| Miscellaneous                |     |        |      * |    |
| Total                        |     | $      |      * |    |

| (1) | This amount excludes a registration fee amount of $13,356.50 associated                                                                      
 with $144,083,090.81 of securities previously registered on the Registration Statement on Form S-3 (File No. 333-266604) and which remain    
 unsold. Pursuant to Rule 415(a)(6) under the Securities Act, the amount of such registration fee associated with the offering                
 of the unsold securities will be carried forward to be applied to the unsold securities registered under this registration statement         
 and no additional filing fee will be due with respect to the unsold securities in connection with the filing of this registration statement. |

| * | Estimated fees and expenses are                                                                                                               
 not presently known. The foregoing sets forth the general categories of fees and expenses (other than underwriting discounts and commissions) 
 that we anticipate we will incur in connection with the offering of securities under this registration statement. An estimate of the          
 aggregate fees and expenses in connection with the issuance and distribution of the securities being offered will be included in the          
 applicable prospectus